Effect of High-Flow Oxygen on Exercise Performance in COPD Patients. Randomized Trial

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology

Background:

• High-flow oxygen therapy (HFOT) delivers heated, humidified air at high flow rates.
• It is a potential alternative to low-flow oxygen therapy (LFOT) for chronic obstructive pulmonary disease (COPD) patients during exercise.

Purpose of the Study:

• To compare the effectiveness of HFOT versus LFOT in improving exercise endurance in COPD patients.
• To evaluate the impact of HFOT on physiological parameters during exercise.

Main Methods:

• A randomized crossover trial involving 79 stable COPD patients (FEV1 40-80%).
• Participants underwent two constant-load cycling tests to exhaustion, receiving either LFOT (3 L/min) or HFOT (60 L/min, FiO2 0.45) in a randomized order.
• Primary outcome was exercise endurance time; secondary outcomes included SpO2, respiratory rate, and dyspnea scores.

Main Results:

• HFOT increased exercise endurance time by 13% (mean difference 85 seconds, P=0.034) compared to LFOT.
• At isotime, HFOT resulted in lower respiratory rates and higher SpO2.
• At end-exercise, SpO2 was 2% higher, and dyspnea scores were reduced by 0.8 points with HFOT.

Conclusions:

• HFOT enhances exercise endurance in mildly hypoxemic COPD patients.
• Improvements are associated with increased SpO2, reduced respiratory rate, and less dyspnea.
• HFOT shows promise for improving exercise performance in COPD management.